Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
St. Luke's Cancer Institute is a comprehensive oncology center and the cancer care division of the St. Luke's Health System, primarily serving Idaho and eastern Oregon. Originally founded in 1969 as the Mountain States Tumor Institute (MSTI), it has grown into a regional leader in cancer treatment, research, and support services. The institute provides access to advanced therapies, including medical, radiation, and surgical oncology, as well as specialized programs in blood and marrow transplantation. As a major clinical research site, it participates in a wide array of Phase 1 through Phase 3 clinical trials in collaboration with national research groups and pharmaceutical partners. The organization is dedicated to providing community-based, high-quality cancer care through its network of multiple regional clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on St Luke's Cancer Institute.